Skip to main content
Market intelligence
ATRAHealthcare

Atara Biotherapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
May 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 18, 2026AnhCo NguyenPresident and CEOSale5,241$9.13$47,845
May 18, 2026Yanina Grant-HuertaChief Accounting OfficerSale2,414$9.13$22,036
May 7, 2026James HuangDirector / 10% OwnerSale313,446$10.10$3,165,021